NASDAQ: MIRA
Mira Pharmaceuticals Inc Stock Ownership - Who owns Mira Pharmaceuticals?

Insider buying vs selling

Have Mira Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Erez AminovCEO and Chairman2025-10-16234,595$1.16
$272.13kBuy
Erez AminovCEO and Chairman2025-10-16379,000$0.84
$318.36kBuy
Erez AminovCEO and Chairman2025-10-16613,595$2.11
$1.29MSell
Denil Nanji ShekhatDirector2025-10-0122,378$1.35
$30.21kBuy

1 of 1

MIRA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MIRA insiders and whales buy or sell their stock.

MIRA Shareholders

What type of owners hold Mira Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Erez Aminov8.55%3,592,666$2.71MInsider
George Cappy6.85%2,879,318$2.17MInsider
Brian Patrick McNulty1.59%670,000$504.51kInsider
Christopher C. Chapman Jr.0.48%200,000$150.60kInsider
Adam Kaplin0.48%200,000$150.60kInsider
Bradley Kroenig0.12%50,000$37.65kInsider
David C. Vorhoff0.10%40,000$30.12kInsider
Hugh McColl Iii0.10%40,000$30.12kInsider
Denil Nanji Shekhat0.05%22,378$16.85kInsider
Talhia Tuck0.05%20,000$15.06kInsider

1 of 3

MIRA vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MIRA0.01%18.36%Net Buying
SCLX0.00%100.00%Net Selling
NSRX0.02%45.43%Net BuyingNet Buying
MDCX0.00%27.07%Net BuyingNet Buying
AMRN0.00%15.85%Net SellingNet Selling

Mira Pharmaceuticals Stock Ownership FAQ

Who owns Mira Pharmaceuticals?

Mira Pharmaceuticals (NASDAQ: MIRA) is owned by 0.01% institutional shareholders, 18.36% Mira Pharmaceuticals insiders, and 81.64% retail investors. Erez Aminov is the largest individual Mira Pharmaceuticals shareholder, owning 3.59M shares representing 8.55% of the company. Erez Aminov's Mira Pharmaceuticals shares are currently valued at $2.57M.

If you're new to stock investing, here's how to buy Mira Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.